Product NDC: | 68968-2030 |
Proprietary Name: | PEXEVA |
Non Proprietary Name: | paroxetine mesylate |
Active Ingredient(s): | 30 mg/1 & nbsp; paroxetine mesylate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 68968-2030 |
Labeler Name: | NOVEN THERAPEUTICS, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA021299 |
Marketing Category: | NDA |
Start Marketing Date: | 20030703 |
Package NDC: | 68968-2030-1 |
Package Description: | 30 TABLET, FILM COATED in 1 BOTTLE (68968-2030-1) |
NDC Code | 68968-2030-1 |
Proprietary Name | PEXEVA |
Package Description | 30 TABLET, FILM COATED in 1 BOTTLE (68968-2030-1) |
Product NDC | 68968-2030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | paroxetine mesylate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20030703 |
Marketing Category Name | NDA |
Labeler Name | NOVEN THERAPEUTICS, LLC |
Substance Name | PAROXETINE MESYLATE |
Strength Number | 30 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |